Results 121 to 130 of about 610,277 (358)

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Timing of initiation of reverse displacement on the Taranaki Fault, northern Taranaki Basin: Constraints from the on land record (Oligocene Te Kuiti Group) [PDF]

open access: yes, 2008
Structures associated with the wedge of basement overthrust into Taranaki Basin along the Taranaki Fault, are regarded as hydrocarbon plays and have been tested by drilling through the tip of the overthrust.
Kamp, Peter J.J.   +1 more
core  

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Abnormal fault-recovery characteristics of the fault-tolerant multiprocessor uncovered using a new fault-injection methodology [PDF]

open access: yes
An investigation was made in AIRLAB of the fault handling performance of the Fault Tolerant MultiProcessor (FTMP). Fault handling errors detected during fault injection experiments were characterized.
Padilla, Peter A.
core   +1 more source

Fault detection and location in DC systems from initial di/dt measurement [PDF]

open access: yes, 2012
The use of DC for primary power distribution has the potential to bring significant design, cost and efficiency benefits to a range of power transmission and distribution applications.
Burt, Graeme   +3 more
core  

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy